Lably
Skip to content

Vascular smooth muscle

Smooth muscle tissue in the walls of blood vessels

  • 2 min read
  • 2 chapters

Related on Lably

Through Blood vessel, Vasoconstriction and Vasodilation

Structure

Vascular smooth muscle refers to the particular type of smooth muscle found within the walls of blood vessels. In some types of blood vessels, it comprises much of the walls, but others (like capillaries) have no smooth muscle.

Nerve supply

Vascular smooth muscle is innervated primarily by the sympathetic nervous system through three types of adrenergic receptors (adrenoceptors): alpha-1, alpha-2 and beta-2 adrenergic receptors. The main endogenous agonist of these cell receptors is norepinephrine (NE).

The adrenergic receptors exert opposite physiologic effects in the vascular smooth muscle under activation:

  • alpha-1 receptors. Under NE binding alpha-1 receptors cause vasoconstriction (contraction of the vascular smooth muscle cells decreasing the diameter of the vessels). These receptors are activated in response to shock or low blood pressure as a defensive reaction trying to restore the normal blood pressure. Antagonists of alpha-1 receptors (doxazosin, prazosin) cause vasodilation (a decrease in vascular smooth muscle tone with increase of vessel diameter and decrease of the blood pressure). (See also receptor antagonist)
  • alpha-2 receptors. Agonists of alpha-2 receptors in the vascular smooth muscle lead to vasoconstriction. However, in clinical practice drugs applied intravenously that are agonists of alpha-2 receptors such as clonidine lead to powerful vasodilation, which causes a decrease in blood pressure by presynaptic activation of the receptors in the sympathetic ganglia. This presynaptic effect is predominant and completely overrides the vasoconstrictive effect of the alpha-2 receptors in the vascular smooth muscle.
  • beta-2 receptors. Agonism of beta-2 receptors causes vasodilation and low blood pressure (i.e. the effect is opposite of the one resulting from activation of alpha-1 and alpha-2 receptors in the vascular smooth muscle cells). Usage of beta-2 receptor agonists as hypotensive agents is less widespread due to adverse effects such as unnecessary bronchodilation in lungs and increase in blood sugar levels.

Sign in to keep reading

One more chapter is free with a Lably account.

More in Health